Chitosan (CS), a biocompatible and biodegradable material, can act as a non-viral delivery vehicle with low toxicity. In this study, plasmid DNA ( pDNA) and siRNA were encapsulated in CS nanoparticles (NPs) to prepare CS -DNA and CS -siRNA NPs using a complex coacervation process. The CS -DNA particle size was within the range of 180 -370 nm with a surface charge ranging from 0 to 18 mV at pH 5.5. The stability of pDNA in CS -DNA was investigated by pDNA release study and DNase I protection assay. The release of pDNA from NPs was studied in pH 7.4 phosphatebuffered saline at 378 8 8 8 8C and the CS-DNA NPs could delay the DNA release. Results of DNase I protection assay showed that CS -DNA NPs could protect the encapsulated pDNA from nuclease degradation. In the transfection study, it was found that the transfection efficiency in vitro was dependent on the molecular weight, charge ratio, and DNA concentration of the CS -DNA NP as well as the type of cell transfected. Moreover, the morphology of HeLa cells transfected with CS -siRNA complexes was studied using atomic force microscopy. The results suggest that CS may be more capable than liposome in delivering siRNA to target cells. In summary, our analysis suggests that pDNA and siRNA can be encapsulated in CS NPs without being damaged.
Introduction
Recently, a number of new techniques have been developed to deliver foreign DNA into cells. Such gene delivery systems include viral (retro-, adeno-, and adeno-associated viruses) and non-viral vectors (liposomes and polymers). Although viral gene delivery systems have high transfection efficiency and are commonly used for in vitro gene transfer, they have major drawbacks compared with non-viral vectors. For example, viral vectors have been reported to induce inflammatory responses, undesirable immune responses, and oncogenic effects [1] .
Non-viral delivery systems are increasingly proposed as a safer alternative to viral vectors due to the following advantages: ease of synthesis, low immune response activation, and unrestricted plasmid size. Among non-viral systems, cationic polymers have gained increasing attention because they can self-assemble with plasmid DNA (pDNA) into polyelectrolyte complexes [2, 3] . Chitosan (CS) is a linear cationic polysaccharide composed of b1 ! 4 linked glucosamine, partly containing N-acetylglucosamine. CS was considered to be a good candidate for gene delivery since it is a biocompatible, biodegradable, and low-toxicity material with high cationic potential [4] . In this study, we proposed a nanoparticle (NP) delivery vehicle synthesized by the complex coacervation of CS with either DNA or siRNA. Its DNA complex formation, protection ability, cell morphous, particle sizes, zeta potential, cytotoxicity, and transfection efficiency were characterized. We investigated the interaction of CS-DNA and CS-siRNA complexes with tumor cells and leukemia cells. Our results showed that the transfection efficiency was affected by the molecular weight of CS, the weight ratio of CS to DNA, the concentration of DNA, and the transfection time.
Materials and Methods

Materials
Oligomer of chitosan (CSO, degree of deacetylation .90%, viscosity of 6 cps), low molecular weight of chitosan (CSL, degree of deacetylation of 75-85%, viscosity of 20 -200 cps) and medium molecular weight of chitosan (CSM, degree of deacetylation of 75 -85%, viscosity of 200-800 cps) were purchased from SigmaAldrich (St Louis, MO, USA). pEGFP-N1 (4.7 kb) encoding green fluorescent protein driven by immediate early promoter of CMV was conserved at our laboratory. siNC-fam (siRNA, 5 0 -carboxyfluorescein) was purchased from Sigma-Aldrich. HeLa cells, A549 lung carcinoma cells, and K562 human immortalized myelogenous leukemia cells were purchased from ATCC (Rockville, MD, USA). DNase I (RNase free, 5 U/ml) was obtained from the TaKaRa (Dalian, China). Lipofectamine TM 2000 was purchased from Invitrogen (Carlsbad, CA, USA).
Preparation of CS-DNA NPs CS-DNA NPs were prepared as described previously [5] . Three types of CS, each of a different molecular weight, were dissolved separately in 0.1 M acetic acid, which was then adjusted to pH 5.5 at a final concentration of 5 mg/ml (stock solution). The stock solution was then diluted with distilled water to form different concentrations of CS solution, ranging from 5 to 500 mg/ml. The CS and the pEGFP-N1 DNA (Clotech, Palo Alto, CA, USA) were first incubated in water bath at 558C for 15 min, respectively. Then CS-DNA complexes were prepared by adding this CS solution (working range of 5-500 mg/ml) to an equal volume of a pDNA solution (50 mg/ml) followed by immediately intense stirring on a vortex mixer for 1 min.
The loading efficiency of pDNA (%) onto CS NPs was obtained by measuring the free pDNA concentration in supernatant recovered after particle centrifugation (14,000 g, 30 min), compared with supernatant recovered from unloaded CS NPs (without pDNA). DNA concentrations were measured using a UV spectrophotometer (Beckman, Fullerton, CA, USA) at 260 nm.
DNA retention and release
The binding of pDNA with CS was determined by agarose gel electrophoresis method [6] . Samples with different CS to pDNA weight ratios, ranging from 0.1 to 10, were loaded onto 1% agarose gel in Tris-acetate/ EDTA (TAE) buffer and electrophoresed at 60 V for 40 min. Then, gels were stained with ethidium bromide and visualized with a UV transilluminator (Beckman).
DNA release study was carried out as reported previously [7] . Briefly, CS-DNA NPs were centrifuged at 48C, 14,000 g for 30 min, after which the pellet was resuspended in 800 ml phosphate-buffered saline (PBS, pH 7.4) and incubated at 378C with 100 rpm agitation. At each specified time point, the mixture was centrifuged at 14,000 g for 30 min and the absorbance at 260 nm was measured to determine the DNA content in the supernatant. The pellet was resuspended in 800 ml PBS and the experiment was repeated over several time points.
Imaging of CS-DNA NPs by atomic force microscopy CS-DNA NPs were scanned by an atomic force microscope as previously described [8] to assess their morphology. Before atomic force microscopy (AFM) imaging, CS-DNA NPs were diluted with distilled water and spontaneously dried on a freshly cleaved mica surface. Then, the mica surface was analyzed using 100-mm scanner and 85-mm-long commercial silicon cantilevers with a spring constant of 25 N/m and an estimated tip radius of 10 nm (ThermoMicroscope, Sunnyvale, CA, USA). The images were recorded at constant force. To avoid low-frequency noise at scanning direction, all images were analyzed with Autoprobe SPM Controller software (ThermoMicroscope).
Measurement of particle size and zeta potential Mean particle diameter and zeta potential of NPs were determined using photon correlation spectroscopy (Brookhaven Instruments, Holtsville, NY, USA) and zeta potential instruments (Brookhaven Instruments), respectively. CS-DNA samples of a w/w ratio of 2 were diluted with distilled water to an appropriate concentration for measurement.
DNase I protection assay CS-DNA NP (40 ml, equivalent to 2 mg DNA) were incubated with 0.5 ml DNase I at 378C for 20 min. The integrity of the pDNA was then analyzed by electrophoresis on 1% agarose gel prepared with 1 Â TAE buffer. Electrophoresis was carried out with 1Â TAE buffer at a constant voltage of 60 V for 40 min, and the DNA bands were visualized under an electronic UV transilluminator. ) . Then, the CS-DNA suspension (500 ml/well) was added. After 6 h of incubation, the media for the HeLa cells were replaced with fresh DMEM containing 10% FBS. The media for the A549 and the K562 cells were replaced with fresh RPMI 1640 medium containing 10% FCS and 20% FBS, respectively. Then the transfected cells were incubated at 378C for an additional 48 h before luciferase activity assay [9] . As a positive control, cells were transfected with Lipofectamine TM 2000-DNA complexes (containing 1 mg of DNA and 2 ml of Lipofectamine TM 2000/well), which were prepared according to the manufacturer's protocol. Naked pDNA (1 mg DNA/well) and untreated cells were used as controls. Transfected cells were digested by trypsin after 72 h and the transfection efficiency was then detected by flow cytometry using the CellQuest System [10] . Experiments were repeated three times, and in each experiment, 10,000 cells were counted.
Cell lines and cell culture
CS-siRNA NPs in vitro transfection siRNA (siNC-fam, 0.1 mg) was diluted in 50 ml RNase-free water containing 25 mM Na 2 SO 4 . The CS solution (5 mg/ml) and the siRNA solution were first incubated in water bath at 558C for 15 min, respectively. Then the CS-siRNA NPs were prepared by adding 50 ml CS solution to an equal volume of siRNA solution (containing 80 nM siRNA) followed by quick stirring. Then the CS-siRNA suspensions (100 ml) were diluted with 400 ml serum-free DMEM. HeLa cells were seeded at a density of 8 Â 10 4 cells/well in 1 ml fresh DMEM containing 10% FBS and incubated in a 24-well plate for 24 h, and then the cells were washed with PBS twice prior to transfection with CS-siRNA (500 ml/well). Six hours after transfection, the medium was replaced with fresh DMEM containing 10% FBS. Cell luciferase activities were analyzed after further incubation of 24 h. Forty-eight hours after transfection, the transfected efficiency was detected by flow cytometry.
Cytotoxicity evaluation
Cytotoxicity studies were performed 72 h after the transfection using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT, Sigma-Aldrich) [11] . HeLa cells were seeded on 96-well plates at a density of 7 Â 10 4 cells/well in 150 ml fresh DMEM supplemented with 10% FBS. Before transfection, after 24 h of incubation, culture medium was discarded, and then CS and CS-DNA suspensions (100 ml) were then added at various concentrations, respectively. After 6 h of incubation, the medium for the HeLa cells was replaced with 150 ml fresh DMEM containing 10% FBS. Cell viability was analyzed using MTT after a further 72 h by measuring absorbance at 570 nm. The viability of non-treated control cells was arbitrarily defined as 100%.
Imaging of HeLa cells by AFM
HeLa cells were scanned by an atomic force microscope to assess their morphology. First, coverslips were placed at well bottom of a 24-well plate. HeLa cells were seeded in a 24-well plate and incubated for 24 h. They were then washed with PBS twice prior to the addition of CS-DNA NP solution at a weight ratio of 2. After 4 h of incubation, the CS-DNA solution was removed and cells were washed with PBS twice. The coverslips were removed from the 24-well plate and semi-air-dried. Then, ice-cold 1.5% glutaraldehyde solution was added to the coverslips as a fixative for 6-10 min at 48C. Before imaging, the coverslips were washed with distilled water and air-dried. The diameter of the CS-DNA NPs was extracted from the AFM topographs by image analysis.
Statistical analysis
Statistical analysis was performed using Student's t-test. A value of P , 0.05 was considered to be significant.
Results
DNA encapsulation capacity of the CS NPs CS polymers showed great ability to form complexes with DNA. The interactions involved in the complex coacervation were mainly electrostatic. The CS-DNA complex encapsulation capacity often depends on the molecular weight of CS. Our results show that the extent of DNA retardation increases with an increasing ratio of CS/DNA (w/w) (Fig. 1) . CS/DNA weight ratio of .0.3 [lane 4 in Fig. 1(A) and lane 4 in Fig. 1(B) ] favors the formation of a macromolecular complex between CS and Chitosan nanoparticles as non-viral gene delivery vehicles nucleic acid. Furthermore, no unbound DNA band was observed in these lanes. At weight ratios of CS/DNA ,0.2, the unbound DNA band was more obvious with the CSL/DNA sample than with the CSM/DNA sample [lane 3 in Fig. 1(A) vs. lane 3 in Fig. 1(B) ]. As these results indicated, complex formation is more efficient at higher molecular weight, which may be due to the fact that larger molecules of CS contain more DNA during formation of complex. Since CSO has a lower molecular weight, the size of the CSO-DNA complex was very small. Therefore, the CSO-DNA complex was not detained [ Fig. 1(C) ]. Figure 2 shows an AFM image of the CSL-DNA complex. In a wide scan of the NP samples, many spherical-shaped structures of similar size were observed [ Fig. 2(A)i] . In a narrow scan, one could clearly see that the CS-DNA particles were aggregated, and the CS NPs appeared to form spherical structures [ Fig. 2(A) ii]. In the three-dimensional map of the CS-DNA particles [ Fig. 2(A) iii], the NPs tend to gather together to form a stable macromolecular material. Some protruded monomeric forms could be seen in the image. Upon analysis of the images, the diameter of the CSL-DNA NPs Size distribution and zeta potential of CS NPs AFM images tended to give smaller size dimensions of the CS NPs than photon correlation spectroscopy. This was mainly due to the sample preparation process. Due to the solvent effect, the size determined by photon correlation spectroscopy was the hydrodynamic diameter and hence was larger than the size measured by AFM [12] . Figure 3 shows the distribution of CSL -DNA and CSM-DNA NP sizes. The CSL-DNA NPs had sizes ranging from 180 to 361 nm. A narrow symmetrical shape could be seen, with the peak value of 238 nm and the mean diameter of roughly 242.6 nm [ Fig. 3(A) ]. After leaving the CSL-DNA standing for a while, the CSL-DNA particles gathered to form macromolecules. As shown in Fig. 3(B) , two plateaus were observed with one at a much higher value. The size of the CSM-DNA NPs ranged from 187 to 371 nm, with the peak value of 246 nm and the mean diameter of $259 nm [ Fig. 3(C) ]. The CSM-DNA complex was a little larger than the CSL-DNA complex under the same conditions. In addition, the CSM-DNA particles were more stable than the CSL-DNA particles.
Morphology of CS NPs
The mean zeta potential of CSL-DNA at pH 5.5 of complex formation was close to zero. Moreover, the mean zeta potential of CSM-DNA was approximately þ18.81 mV. CSM-DNA had more positive charge on its surface; therefore, it was more stable than CSL -DNA and did not tend to aggregate easily.
DNA release profiles from CSL-DNA NPs
To evaluate the stability of CS-DNA complexes (CSL-DNA), the release behavior of CS-DNA NPs was determined at different time points using a UV spectrophotometer. In the first 24 h, the DNA content in the supernatant did not increase obviously, indicating that the release rate was very slow (Fig. 4) . After 24 h, CS-DNA underwent a process of rapid release (P , 0.01). The DNA content in the supernatant at the 72nd hour was 6.12 mg/ml and the pDNA loading efficiency was 87.8%. It can be concluded that the self-aggregated NPs had delayed the DNA release.
Protection of condensed DNA against nuclease degradation
The effect of CS protecting pDNA from DNase I degradation was examined using CSM/CSL and DNase I as a model enzyme (Fig. 5) . Upon incubation with DNase I, naked pDNA (as a control) was completely degraded [lane 2 in Fig. 5(A,B) ]. In contrast, pDNA recovered from CSM NPs remained intact after DNase I treatment [lanes 4 and 5 in Fig. 5(A) ]. When CSM/DNA weight ratio was ,4, the intensities of the bands decreased obviously, indicating that DNA encapsulated in CS was partially degraded. For the CSL -DNA complexes Fig. 4 Release profiles of CS -DNA NPs in PBS ( pH 7.4) At each specified time point, the mixture was centrifuged at 14,000 g for 30 min and the absorbance at 260 nm was measured to determine the DNA content in the supernatant. Results are expressed as the mean + SD (n ¼ 3). *P , 0.01 compared with the time point of 24 h. 
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[ Fig. 5(B) ], poorer DNA protection was found compared with CSM-DNA under the same conditions. The bands detained were dim, suggesting that the higher weight ratio and molecular weight gave higher DNA-binding strength and capability to protect DNA from DNase I. Similar findings have also been reported by Lee et al. [2] In vitro transfection of CS-DNA NPs
General applicability of CS -DNA NPs
The pEGFP-N1 plasmid can translate and express green fluorescent protein in eukaryotic cells. It has been demonstrated that transfecting this plasmid into cells without any carrier had very low transfection efficiency [13, 14] . Figure 6 showed that green fluorescence could be seen in all the three cell lines 48 h after transfection with CSL -DNA NPs: HeLa, A549, and K562. This indicates that CS-DNA NPs can be transfected and express green fluorescent protein in many cell types. CSO and CSM were not investigated in this study. The CS-DNA complex transfection efficiency was measured by counting the green fluorescent using fluorescenceactivated cell sorting (FACS). The transfection efficiencies of CSL-DNA NP in HeLa cells, A549, and K562 were 9.14%, 8.21%, and 3.33%, respectively, which were obviously higher than those of the negative control naked DNA (0.05%), but lower than those of the positive control Lipofectamine TM 2000 (79.22%, 58.78%, and 27.90%, respectively) (Fig. 7) . CS-DNA NPs had much lower transfection efficiency in K562 cells than HeLa or A549 cells. The transfection in HeLa cells gave the highest fluorescence. Such cell-type dependence of CS-DNA complexes was also reported previously [15, 16] .
Efficiency of different formulations
There are many reports on the transfection of mammalian cells with polymer/DNA systems. Transfection of the particulate DNA system can be affected by many factors including the molecular weight of the polymer, amount of DNA, the ratio of the polymer/DNA, the viability of the cells, and the cell lines used [17] . In this study, CS-DNA complexes were prepared with CS of different molecular weights (CSO-DNA, CSL-DNA, and CSM-DNA). The results show that fluorescence was observed in CSL-DNA and CSM-DNA groups but not in CSO-DNA group. Figure 8 shows the comparison of transfection efficiency in HeLa cell between CSL-DNA and CSM-DNA. When the weight ratio of CS-DNA complexes was 0.5, 1, 2, and 4, the transfection efficiencies of CSL -DNA were 5.53%, 11.37%, 9.33%, and 3.16%, respectively, whereas those of CSM-DNA were 3.68%, 7.63%, 5.67%, and 1.05%, respectively. CSL has lower molecular weight than CSM, and the size of CSL-DNA complex was smaller, which was easily transfected into cells. Thus, CSL-DNA complexes had higher transfection efficiency than CSM-DNA under the same conditions. These results indicate that the CS molecular weight had influence on complex transfection in vitro.
CS-DNA NPs of various weight ratios affected the transfection efficiency in HeLa cells (Fig. 8) . Weight ratio of 1/1 of CS/DNA leads to better expression in HeLa cells than other ratios. The ratio of CS/DNA NPs determined the degree of the stability of coupling to the DNA and also the total mass that was introduced into the cells. Also, the charge ratio has been shown to be important for transfection efficiency in vitro [18] .
The transfection efficiency of the CS-DNA complex in HeLa cells is also correlated positively with the amount of DNA and the incubation time (data not shown).
In vitro transfection of CS-siRNA complexes
In this experiment, CS of various molecular weights was investigated as potential delivery systems for siRNA in vitro. Until recently, only cationic lipids were thought to be efficient siRNA delivery systems in vitro [19] [20] [21] . In this study, CS of three different molecular weights was used to deliver siRNA labeled with a green fluorescent marker at its 5 0 -end into the HeLa cell. Lipofectamine 
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2000 was used as a positive control. After culturing for 24 h, green fluorescence was seen in the CSM and CSL groups (Fig. 9) , which was similar to the Lipofectamine TM 2000 group. These results suggest that CSL and CSM NPs can efficiently deliver siRNA into the HeLa cell. In contrast, green fluorescence was not seen in CSO group under the same conditions (data not shown). The transfection efficiency of CS-siRNA complexes in HeLa cells was measured by counting the green fluorescent marker of siNC-fam using FACS. When the final concentration of CS was at 1 mg/ml, the transfection efficiencies of CSL and CSM were 4.47% and 4.18%, respectively. It was obviously higher than the negative control siRNA, which was 0.04%. As the working concentration increased, the intensity of green fluorescence increased. The transfection efficiencies of CSL and CSM reached 22.32% and 32.06% at the concentration of 15 mg/ml, respectively. The transfection efficiency of CSM was higher than CSL.
However, the transfection efficiency of the positive control Lipofectamine TM 2000-siRNA was 36.84% at the lower concentration of 5 mg/ml. Figure 10 showed an AFM image of HeLa cells. One can clearly see that the non-transfected HeLa cell appeared to be fusiform, whereas the periphery of cytoplasm was radial. In the cell ultrastructure image, the nucleus and major cell organelles gathered in the center of the cell, which was protruded. In the threedimensional map of the cell ultrastructure, the surface of the cell was smooth.
Morphology of HeLa cells transfected with CS-siRNA
Compared with the non-transfected HeLa cell, the size of that transfected with CSM-siRNA was not altered. However, the surface of transfected cell was no longer smooth and became very rough. In the three-dimensional 
Cytotoxicity of CS and CS-DNA complexes
In this study, the viability of non-treated control cells was arbitrarily defined as 100%. Figure 11 showed the cytotoxicity of CS to HeLa cells. The viability of cells treated with Lipofectamine TM 2000 was $75.3% at 0.5 mg/ml. CSO showed little cytotoxicity to HeLa cells at concentrations from 3.125 to 50 mg/ml. CSL and CSM both showed low cell toxicity at 4 mg/ml with cell viability over 90%. As the concentration of CS surpassed 4 mg/ml, the cell viability began to decrease and CSL showed slight cytotoxicity compared with CSM (P , 0.01). The cytotoxicity of CS-pDNA NPs of different concentrations was examined in HeLa cells after 72 h of transfection. Figure 12 showed that as the concentration of CSL-DNA and CSM-DNA complexes increased, the cell viability gradually decreased. Compared with the CSL-DNA complex, CSM-DNA showed higher cytotoxicity (P , 0.01). The result indicates that CSL-DNA and CSM-DNA had little cytotoxicity on HeLa cells at concentrations of 3-24 mg/ml. Discussion CS was first described as a delivery system for plasmids by Mumper et al. [4] CS has been considered to be a good candidate for gene delivery system since it is Chitosan nanoparticles as non-viral gene delivery vehicles a biocompatible, biodegradable material that can act as a non-viral delivery vehicle with low toxicity. In this study, CS-DNA and CS-siRNA NPs were successfully prepared using a complex coacervation process under defined conditions and used as an effective gene delivery system. In the CS-based aqueous system, there are electrostatic interactions, hydrophobic interactions, and H-bonding, all of which will influence the solubility or assembly behaviors of CS and/or its derivatives [22, 23] . The cationic characteristic of CS is a crucial parameter for complex formation [24] . Therefore, it is likely that in acidic conditions, the positively charged CS forms a complex with the negatively charged DNA by electrostatic interactions. In this study, the simple complexation methods were chosen to prepare CS-DNA and CS-siRNA complexes since the processes are simple and mild. Particle size and shape play an important role in transferring genes into the cells. It has been reported that particles in the nanometer size have a relatively higher intracellular uptake compared with microparticles [25] . This characteristic is very important in gene transfer because cellular uptakes of the CS-DNA complex as well as its subsequent release from the endo-lysosome pathway are two of the rate-limiting steps in this process [26] . In our study, we tried to obtain NPs of ,400 nm to facilitate the uptake of the particles. The results showed that smaller particle size was obtained and the CS-DNA particle had sizes of 180-370 nm, with a surface charge of 0-18 mV at pH 5.5. This hydrophobic nature helped to stabilize the NPs without cross-linking and protect the encapsulated pDNA from nuclease Chitosan nanoparticles as non-viral gene delivery vehicles degradation. This revealed that CS had potential to delivery pDNA into cell nucleus without being damaged.
In the transfection study, it was found that the transfection efficiency of CS-DNA NPs was cell-type-dependent. There are several reports stating successful Chitosan nanoparticles as non-viral gene delivery vehicles CS-mediated transfection [18, 27] . However, the relationship between transfection efficiency and different formulations has not to be clearly illustrated. Our study fully demonstrated this relationship by means of complexes formed with pEGFP-N1 plasmid. The variables of formulation, including the molecular weight of CS, the weight ratio of complexes, the DNA concentration, and the incubation time, determine the in vitro transfection efficiency of the complexes. In this study, CSL-DNA complexes had the higher transfection efficiency compared with CSM -DNA under the same conditions, and while the weight ratio of CS/DNA was 1/1, it led to better expression in HeLa cells than other ratios. Our results exhibited that the molecular weight of CS and the weight ratio of CS/DNA NPs determined the stability of the CS-DNA complexes and also the total mass that was introduced into the cells. In addition, CSs of various molecular weights were investigated as potential delivery systems for siRNA in vitro in our study. The ability of these CS NPs in delivering siRNA to the cells was independent of the molecular weight of CS. In the case of CS as siRNA delivery system, the effects of different CS-siRNA complexes on transfection activity had been observed previously [28] . Nonetheless, there was no study that attempted to illustrate the morphology of HeLa cells transfected with CS-siRNA complexes. Therefore, we analyzed the morphology of HeLa cells transfected with CS-siRNA complexes by AFM. In Fig. 10 , one can see that the surface of the cell was no longer smooth; instead, it became very rough compared with normal cells. Moreover, the transfected cell had lots of holes of different sizes and depth on the surface. These results suggested that CS has potential in delivering siRNA to target cells and implied that the cell uptake of CS-siRNA complexes might be endocytosed. It can be concluded from these results that DNA or siRNA can be encapsulated in the CS NPs without being damaged using the method described in the study. The results suggested that CS could be more potential for delivering pDNA and siRNA to target cells. Further studies would focus on evaluating in vivo transfection efficiency of this delivery system.
Fig. 11 Cytotoxicity of CS to HeLa cells
Cytotoxicity studies were performed 72 h after the transfection using MTT. The absorbance of the samples was measured at 570 nm. The viability of non-treated control cells was arbitrarily defined as 100%. Results are expressed as the mean + SD (n ¼ 4). *P , 0.01 compared with CSM.
Fig. 12 Cytotoxicity of CS-DNA complexes to HeLa cells
Cytotoxicity studies were performed 72 h after the transfection using MTT. The absorbance of the samples was measured at 570 nm. The viability of non-treated control cells was arbitrarily defined as 100%. Results are expressed as the mean + SD (n ¼ 4). *P , 0.01 compared with CSM-DNA.
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